BeOne Medicines AG (BEIGF)

BeOne Medicines AG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 7, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	35,168	33,619	19,667	18,862	22,843	27,843
Market Cap Growth	47.58%	70.94%	4.27%	-17.43%	-17.96%	18.51%
Enterprise Value	31,713	30,602	18,005	16,441	18,473	24,626
Last Close Price	24.92	24.92	14.02	14.29	16.70	-
PE Ratio	122.56	117.17	-	-	-	-
PS Ratio	6.58	6.29	5.16	7.67	16.13	23.67
PB Ratio	8.06	7.71	5.90	5.33	5.21	4.54
P/TBV Ratio	8.18	7.82	5.99	5.42	5.26	4.58
P/FCF Ratio	37.34	35.70	-	-	-	-
P/OCF Ratio	31.19	29.82	-	-	-	-
EV/Sales Ratio	5.94	5.73	4.72	6.69	13.05	20.94
EV/EBITDA Ratio	53.32	52.87	-	-	-	-
EV/EBIT Ratio	73.38	68.44	-	-	-	-
EV/FCF Ratio	33.68	32.49	-	-	-	-
Debt / Equity Ratio	0.25	0.25	0.32	0.26	0.14	0.11
Debt / EBITDA Ratio	1.79	1.79	-	-	-	-
Debt / FCF Ratio	1.16	1.16	-	-	-	-
Net Debt / Equity Ratio	-0.79	-0.79	-0.46	-0.63	-0.90	-0.97
Net Debt / EBITDA Ratio	-5.97	-5.97	3.86	2.00	2.28	4.25
Net Debt / FCF Ratio	-3.67	-3.67	2.44	1.30	2.16	3.80
Asset Turnover	0.76	0.76	0.65	0.40	0.19	0.17
Inventory Turnover	1.21	1.21	1.30	1.09	1.09	0.99
Quick Ratio	2.97	2.97	1.51	1.97	3.22	4.45
Current Ratio	3.41	3.41	1.80	2.32	3.55	4.76
Return on Equity (ROE)	7.46%	7.46%	-18.77%	-22.26%	-38.11%	-29.15%
Return on Assets (ROA)	3.96%	3.96%	-6.06%	-12.39%	-15.00%	-12.72%
Return on Invested Capital (ROIC)	30.49%	22.87%	-36.89%	-138.75%	-549.14%	-
Return on Capital Employed (ROCE)	7.00%	7.00%	-15.30%	-30.20%	-36.40%	-20.70%
Earnings Yield	0.82%	0.85%	-3.28%	-4.67%	-8.77%	-5.24%
FCF Yield	2.68%	2.80%	-3.22%	-9.12%	-7.98%	-5.61%
Buyback Yield / Dilution	-7.75%	-7.75%	-0.86%	-1.22%	-11.15%	-11.16%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.